Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Shareholders' Equity

v3.21.2
Condensed Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Treasury Stock
Additional Paid- In Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings (Accumulated Deficit)
Beginning balance at Sep. 30, 2019 $ 87,452 $ 143   $ 125,098 $ (11,233) $ (26,556)
Beginning balance (in shares) at Sep. 30, 2019   14,269,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (1,932)         (1,932)
Translation adjustment 2,673       2,673  
Stock compensation expense 68     68    
Stock options exercised 701 $ 1   700    
Stock options exercised (in shares)   117,000        
Ending balance at Dec. 31, 2019 88,962 $ 144   125,866 (8,560) (28,488)
Ending balance (in shares) at Dec. 31, 2019   14,386,000        
Beginning balance at Sep. 30, 2019 87,452 $ 143   125,098 (11,233) (26,556)
Beginning balance (in shares) at Sep. 30, 2019   14,269,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (13,698)          
Ending balance at Jun. 30, 2020 82,251 $ 140   124,289 (1,792) (40,386)
Ending balance (in shares) at Jun. 30, 2020   14,048,000        
Beginning balance at Dec. 31, 2019 88,962 $ 144   125,866 (8,560) (28,488)
Beginning balance (in shares) at Dec. 31, 2019   14,386,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (11,694)         (11,694)
Translation adjustment 6,746       6,746  
Stock compensation expense 65     65    
Stock repurchases $ (2,000)   $ (2,000)      
Stock repurchases (in shares) (366,000)   (366,000)      
Retirement of stock repurchases   $ (4) $ 2,000 (1,864)   (132)
Retirement of stock repurchases (in shares)   (366,000) 366,000      
Stock options exercised $ 78     78    
Stock options exercised (in shares)   21,000        
Ending balance at Mar. 31, 2020 82,157 $ 140   124,145 (1,814) (40,314)
Ending balance (in shares) at Mar. 31, 2020   14,041,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (72)         (72)
Translation adjustment 22       22  
Stock compensation expense 124     124    
Stock options exercised 20     20    
Stock options exercised (in shares)   7,000        
Ending balance at Jun. 30, 2020 82,251 $ 140   124,289 (1,792) (40,386)
Ending balance (in shares) at Jun. 30, 2020   14,048,000        
Beginning balance at Sep. 30, 2020 $ 81,519 $ 141   124,435 (646) (42,411)
Beginning balance (in shares) at Sep. 30, 2020 14,063,172 14,063,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) $ 719         719
Translation adjustment 595       595  
Stock compensation expense 65     65    
Stock options exercised 135     135    
Stock options exercised (in shares)   28,000        
Ending balance at Dec. 31, 2020 83,033 $ 141   124,635 (51) (41,692)
Ending balance (in shares) at Dec. 31, 2020   14,091,000        
Beginning balance at Sep. 30, 2020 $ 81,519 $ 141   124,435 (646) (42,411)
Beginning balance (in shares) at Sep. 30, 2020 14,063,172 14,063,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) $ 842          
Ending balance at Jun. 30, 2021 $ 83,540 $ 143   125,858 (892) (41,569)
Ending balance (in shares) at Jun. 30, 2021 14,252,978 14,253,000        
Beginning balance at Dec. 31, 2020 $ 83,033 $ 141   124,635 (51) (41,692)
Beginning balance (in shares) at Dec. 31, 2020   14,091,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (246)         (246)
Translation adjustment (225)       (225)  
Stock compensation expense 84     84    
Stock options exercised 795 $ 1   794    
Stock options exercised (in shares)   131,000        
Ending balance at Mar. 31, 2021 83,441 $ 142   125,513 (276) (41,938)
Ending balance (in shares) at Mar. 31, 2021   14,222,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 369         369
Translation adjustment (616)       (616)  
Stock compensation expense $ 128     128    
Stock repurchases (in shares) 0          
Stock options exercised $ 218 $ 1   217    
Stock options exercised (in shares)   31,000        
Ending balance at Jun. 30, 2021 $ 83,540 $ 143   $ 125,858 $ (892) $ (41,569)
Ending balance (in shares) at Jun. 30, 2021 14,252,978 14,253,000